1. Identify deletion mutations in the RB1 gene in retinoblastoma patients by MLPA method
Main Article Content
Abstract
Retinoblastoma (RB) is a common ocular malignancy in children under 5 years of age, caused by mutations in the RB1 gene. The disease occurs in two forms, sporadic and familial form. The disease causes severe ocular damage, which can lead to ophthalmectomy, metastasis, and death by many different RB1 gene mutations, of which about 20% of cases have deletions greater than 1kb and 30% have smaller segment loss or repeats. Nowadays, the MLPA technique is the preferred method of choice in diagnosing large deletion mutations, repeating segments with high accuracy and quick results. The study was carried out on peripheral blood and tissue samples of 20 UNBVM patients to detect genetic germ cell mutations and somatic mutations by MLPA technique. The results detected that 2/20 patients (10%) had a heterozygous deletion mutation of the whole RB1 gene in both blood and tissue samples.
Article Details
Keywords
Retinoblastoma, RB1, MLPA
References
2. Nguyen Hai Ha, Nguyen Thị Thanh Hoa, Vu NP, et al. Mutational screening of germline RB1 gene in Vietnamese patients with retinoblastoma reveals three novel mutations. Mol Vis. 2018; 24:231-238.
3. Retinoblastoma - Springer US (2010) (Pediatric Oncology) Michael A. Dyer, Carlos Rodriguez-Galindo, Matthew W. Wilson.
4. Nguyen Công Kiet, Le Thai Khuong, Do Minh Duc, et al. Spectrum of mutations in the RB1 gene in Vietmamese patients with retinoblastoma. Moi Vs. 2019; 25:215-221.
5. Tomor S, Sethi R, Sundar G, Quah TC, Quah BL, Lai PS. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counselling. PloS One. 2017; 12(6): e0178776. doi: 10.1371/jourmal. Pone.0178776.
6. Tomar s. Sethi R, Sundar G, Quah TC, Quan BL Lai PS. Mutation spectrum of RB1 mutations in retinoblastoma cases from Singapore with implications for genetic management and counseling. Plos one. 2017; 12(6): e0178776. doi:10.1371jourmal.pone.0178776.
7. Xie Y. Xu XL, Wei WB. The RB1 Mutation Spectrum and Genetic Management Consultation in Pediatric Patients with Retinoblastoma in Befjing, China. Risk management and healthcare policy. 2021; 14:3453-3463.dii:10.2147/mhp.S322373.
8. Valverde J, Alonso J, Palacios I, Pestana A. RB1 gene mutation up-date, a meta-analysis based on 932 reported mutations available in a searchable database. BMC genetics. Nov 4 2005; 6:53. doi:10.1186/1471-2156-6-53
9. Frenkel S, Zloto O, Sagi M, Fraenkel A, Pe’ẻ J. Genotype-phenotype correlation in the presentation of retinoblastoma among 149 patients. Exp Eye Res. May 2016; 146:313-317. Doi:10.1016/j.exer.2016.04.002.
10. Gao I, Zeng J, Guo B. He w. Chen J. Lu F. Chen D (2016). Clinical presentation and treatment outcome of retinoblastoma in children of Sourh Westermn China. Medicine (Baitimore). 95(42), e5204.